1 year return (CAGR)
115.29%
Calliditas Therapeutics Exchange (NASDAQ, USD)
CALT
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
21.29%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.08B
Price/Sales
0.67
Ent value
1.92B
Price/Book
10.12
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
6.33
EPS growth
11.28%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 40.00 |
| Daily high | 40.00 |
| Daily low | 40.00 |
| Daily Volume | 0K |
| 1y analyst estimate | 39.25 |
| Beta | 1.46 |
| EPS (TTM) | -8.95 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CALT | S&P500 | |
| Current price drop from All-time high | -3.73% | -0.14% |
| Highest price drop | -68.62% | -56.47% |
| Date of highest drop | 20 Oct 2022 | 9 Mar 2009 |
| Avg drop from high | -34.45% | -10.68% |
| Avg time to new high | 54 days | 12 days |
| Max time to new high | 877 days | 1805 days |
News
No items found